$2500 | Single User
$5000 | Site License
$7500 | Global License

Renal Artery Stenosis Global Clinical Trials Review, H1, 2018
[Report Updated: 29-06-2018]

Published by Global Data: 29 Jun 2018 | 220919 | In Stock
Related Topics: Clinical Trials

Introduction

Renal Artery Stenosis Global Clinical Trials Review, H1, 2018

Summary

GlobalData's clinical trial report, “Renal Artery Stenosis Global Clinical Trials Review, H1, 2018" provides an overview of Renal Artery Stenosis clinical trials scenario. This report provides top line data relating to the clinical trials on Renal Artery Stenosis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData’s proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides a snapshot of the global clinical trials landscape

- Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status

- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company

- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment

- The Report provides enrollment trends for the past five years

- Report provides latest news for the past three months

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

- Assists in formulating key business strategies with regards to investment

- Helps in identifying prominent locations for conducting clinical trials which saves time and cost

- Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities

- Supports understanding of trials count and enrollment trends by country in global therapeutics market

- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials

- Facilitates clinical trial assessment of the indication on a global, regional and country level

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Table of Contents
for Renal Artery Stenosis Global Clinical Trials Review, H1, 2018 [Report Updated: 29-06-2018]

  • Table of Contents

    Table of Contents 2

    List of Tables 3

    List of Figures 3

    Report Guidance 4

    GlobalData Clinical Trials Report Coverage 5

    Clinical Trials by Region 6

    Clinical Trials and Average Enrollment by Country 7

    Top Countries Contributing to Clinical Trials in Asia-Pacific 9

    Top Countries Contributing to Clinical Trials in Europe 10

    Top Countries Contributing to Clinical Trials in North America 11

    Top Countries Contributing to Clinical Trials in Middle East and Africa 12

    Clinical Trials by G7 Countries: Proportion of Renal Artery Stenosis to Cardiovascular Clinical Trials 13

    Clinical Trials by Phase in G7 Countries 14

    Clinical Trials in G7 Countries by Trial Status 15

    Clinical Trials by E7 Countries: Proportion of Renal Artery Stenosis to Cardiovascular Clinical Trials 16

    Clinical Trials by Phase in E7 Countries 17

    Clinical Trials in E7 Countries by Trial Status 18

    Clinical Trials by Phase 19

    In Progress Trials by Phase 20

    Clinical Trials by Trial Status 21

    Clinical Trials by End Point Status 22

    Subjects Recruited Over a Period of Time 23

    Clinical Trials by Sponsor Type 24

    Prominent Sponsors 25

    Top Companies Participating in Renal Artery Stenosis Therapeutics Clinical Trials 26

    Prominent Drugs 27

    Clinical Trial Profile Snapshots 28

    Appendix 36

    Abbreviations 36

    Definitions 36

    Research Methodology 37

    Secondary Research 37

    About GlobalData 38

    Contact Us 38

    Source 38

List Of Tables
in Renal Artery Stenosis Global Clinical Trials Review, H1, 2018 [Report Updated: 29-06-2018]

List of Tables

Renal Artery Stenosis Therapeutics, Global, Clinical Trials by Region, 2018* 6

Renal Artery Stenosis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2018* 7

Renal Artery Stenosis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2018* 8

Renal Artery Stenosis Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2018* 9

Renal Artery Stenosis Therapeutics Clinical Trials, Europe, Top Countries, 2018* 10

Renal Artery Stenosis Therapeutics Clinical Trials, North America, Top Countries, 2018* 11

Renal Artery Stenosis Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2018* 12

Proportion of Renal Artery Stenosis to Cardiovascular Clinical Trials, G7 Countries (%), 2018* 13

Renal Artery Stenosis Therapeutics, G7 Countries, Clinical Trials by Phase, 2018* 14

Renal Artery Stenosis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2018* 15

Proportion of Renal Artery Stenosis to Cardiovascular Clinical Trials, E7 Countries (%), 2018* 16

Renal Artery Stenosis Therapeutics, E7 Countries, Clinical Trials by Phase, 2018* 17

Renal Artery Stenosis Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2018* 18

Renal Artery Stenosis Therapeutics, Global, Clinical Trials by Phase, 2018* 19

Renal Artery Stenosis Therapeutics, Global, Clinical Trials In Progress by Phase 2018* 20

Renal Artery Stenosis Therapeutics, Global, Clinical Trials by Trial Status, 2018* 21

Renal Artery Stenosis Therapeutics Clinical Trials, Global, by End Point Status, 2018* 22

Renal Artery Stenosis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2013-2017 23

Renal Artery Stenosis Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2018* 24

Renal Artery Stenosis Therapeutics Clinical Trials, Global, Key Sponsors, 2018* 25

Renal Artery Stenosis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2018* 26

Renal Artery Stenosis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2018* 27

List Of Figures, Charts and Diagrams
in Renal Artery Stenosis Global Clinical Trials Review, H1, 2018 [Report Updated: 29-06-2018]

List of Figures

Renal Artery Stenosis Therapeutics, Global, Clinical Trials by Region (%), 2018* 6

Renal Artery Stenosis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2018* 7

Renal Artery Stenosis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2018* 8

Renal Artery Stenosis Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2018* 9

Renal Artery Stenosis Therapeutics Clinical Trials, Europe, Top Countries (%), 2018* 10

Proportion of Renal Artery Stenosis to Cardiovascular Clinical Trials, G7 Countries (%), 2018* 13

Renal Artery Stenosis Therapeutics, G7 Countries, Clinical Trials by Phase, 2018* 14

Renal Artery Stenosis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2018* 15

Proportion of Renal Artery Stenosis to Cardiovascular Clinical Trials, E7 Countries (%), 2018* 16

Renal Artery Stenosis Therapeutics, E7 Countries, Clinical Trials by Phase, 2018* 17

Renal Artery Stenosis Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2018* 18

Renal Artery Stenosis Therapeutics, Global, Clinical Trials by Phase (%), 2018* 19

Renal Artery Stenosis Therapeutics, Global, Clinical Trials In Progress by Phase, 2018* 20

Renal Artery Stenosis Therapeutics, Global, Clinical Trials by Trial Status, 2018* 21

Renal Artery Stenosis Therapeutics Clinical Trials, Global, by End Point Status, 2018* 22

Renal Artery Stenosis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2013-2017 23

Renal Artery Stenosis Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2018* 24

Renal Artery Stenosis Therapeutics Clinical Trials, Global, Key Sponsors, 2018* 25

Renal Artery Stenosis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2018* 26

Renal Artery Stenosis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2018* 27

GlobalData Methodology 37

Additional Details

Publisher

Global Data

Publisher Information

Reference

220919 | GDHC5089CTIDB

Number of Pages

38

Report Format

PDF

Global Data Reports

Related Reports

TitleDate PublishedPrice fromMore Details
Global Renal Failure Partnering 2010 to 2016
The Global Therapy Partnering Terms and Agreements since 2010 report provides understanding and acce...
01 Oct 2016 by Current Partnering USD $1,495 More Info
U.S. Renal Care Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile
SummaryU.S. Renal Care Inc. (U.S. Renal Care) is a healthcare service provider that offers in-center...
10 May 2016 by Global Data USD $250 More Info
Market Access Impact: Renal Cell Carcinoma (US)
IntroductionMarket barriers boost net share for 6 major RCC treatments in US. Is your brand one of t...
01 May 2016 by FirstWord Pharma USD $4,995 More Info
Market Access Impact: Renal Cell Carcinoma (EU5)
IntroductionMarket barriers cause net share loss for 5 major RCC treatments in Europe. Is your brand...
01 May 2016 by FirstWord Pharma USD $4,995 More Info
Medical Affairs Reputations: Renal Cell Carcinoma (US)
IntroductionOpdivo’s medical affairs team working overtime to engage oncologists. Is it paying off?O...
01 Apr 2016 by FirstWord Pharma USD $5,995 More Info
Medical Affairs Reputations: Renal Cell Carcinoma (EU5)
Introduction4 medical affairs teams working hard to engage oncologists. Which one gets top marks? Eu...
01 Apr 2016 by FirstWord Pharma USD $5,995 More Info
U.S. Renal Care Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile
SummaryU.S. Renal Care, Inc. (U.S. Renal Care) is a healthcare service provider that offers in-cente...
17 Mar 2016 by Global Data USD $250 More Info
NPS+ Renal Cell Carcinoma (US)
IntroductionTwo brands lead the RCC treatment market. How does your brand stack up?US oncologists ma...
01 Feb 2016 by FirstWord Pharma USD $2,495 More Info
NPS+ Renal Cell Carcinoma (EU5)
IntroductionCompare 8 major RCC brands. Learn which one scores 6 times higher than any other?FirstVi...
01 Feb 2016 by FirstWord Pharma USD $2,495 More Info
Renal Cell Carcinoma: KOL Insight
IntroductionWill new checkpoint inhibitors revive immunotherapy in RCC?Renal Cell Carcinoma: KOL Ins...
01 Feb 2015 by FirstWord Pharma USD $7,900 More Info

This report is published by Global Data

Download Free Report Summary PDF

Renal Artery Stenosis Global Clinical Trials Review, H1, 2018 [Report Updated: 29-06-2018] | Download PDF Summary

Download our FREE report summary PDF. It contains all the information on these web pages, plus a Proforma Invoice request form, should you need it to satisfy your company's internal order procedures.

Ordering Information

Orders are processed immediately and you will be notified of the despatch date on confirmation of your order.

Accepted Card Types

Payment

Buy now using our secure payment system.

We Stock...

  • 360i Research
  • 99Strategy
  • Allied Market Research
  • Asia Market Information & Development Co.
  • Azoth Analytics
  • BioInformant
  • Black Swan Analysis
  • Canadean
  • CBR Pharma Insights
  • CRI
  • Current Analysis
  • Current Partnering
  • Daedal Research
  • Data bridge
  • Delve Insight
  • DPI Research
  • FirstWord Pharma
  • Future Market Insights
  • GBI Research
  • Global Data
  • Global Markets Direct
  • Global Research and Data Services GRDS
  • GMR Data
  • HeyReport
  • HongChun
  • HTStec
  • ICD Research
  • iGATE Research
  • IMARC
  • Industry ARC
  • Inkwood Research
  • IQ4I
  • Jain PharmaBiotech
  • Kelly Scientific
  • La Merie
  • Lifescience Intellipedia
  • LP Information
  • Market Data Forecast
  • Market Research Future
  • Marketline
  • MarketsandMarkets
  • McDerson
  • MedMarket Diligence
  • Meticulous Research
  • MicroMarketMonitor
  • MIReports
  • Mordor Intelligence LLC
  • MP Advisors
  • Occams Business Research
  • Prof Research
  • Progressive Markets
  • ProGrow Pharma Partners
  • Renub
  • Research Impact
  • RNCOS
  • Rockville Research
  • S&P Consulting
  • StratisticsMRC
  • The Business Research Company
  • Triton Market Research
  • Venture Planning Group (VPG)